Clinical Trials Logo

Filter by:
  • Completed  
  • Page [1] ·  Next »
NCT ID: NCT06442410 Completed - Pain, Chronic Clinical Trials

Comparison of DTM™ SCS Therapy Combined With Conventional Medical Management (CMM) to CMM Alone in the Treatment of Intractable Back Pain Subjects Without Previous History of Lumbar Spine Surgery

Start date: July 24, 2020
Phase: N/A
Study type: Interventional

The purpose of this investigational study is to document the safety, clinical effectiveness and health economic analytics of DTM™ SCS programming delivered through the Intellis™ neurostimulator in subjects with chronic, intractable pain of the trunk with or without lower limb pain, including unilateral or bilateral pain without prior history of spine surgery and refractory to conservative treatment and are not candidates for lumbar spinal surgery.

NCT ID: NCT06414486 Completed - Stress Clinical Trials

Effects of Ginseng on Stress, Emotional and Cognitive Processing

GNIZEN
Start date: May 12, 2023
Phase: N/A
Study type: Interventional

This study aims to confirm the positive effect of the Red Panax Ginseng on the cognitive performance and regulation of stress and fatigue in adults with moderate stress level.

NCT ID: NCT06410326 Completed - Multiple Sclerosis Clinical Trials

Mapping the Longitudinal, Multidimensional Impact of MS in Relation to Variables Indicative of Neurological Reserve

Resilience
Start date: April 1, 2024
Phase:
Study type: Observational

Some MS patients quickly accumulate neurological deficits, while others remain well for decades. Even though associations with age, sex, health behaviors, comorbidities and social determinants of health are widely acknowledged, the clinical heterogeneity in MS is poorly understood and variables with a robust prognostic value are lacking. Recent data suggest a key role for resilience in the central nervous system, potentially supporting the concept of neurological reserve in MS.

NCT ID: NCT06397508 Completed - Healthy Volunteers Clinical Trials

Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants

Start date: April 2, 2024
Phase: Phase 1
Study type: Interventional

This is a single-center, open-label, single-dose, randomized, 3-period cross-over, Phase 1 study in healthy adult participants to assess the BA of AGMB-129 tablet formulation relative to that of the reference capsule formulation and to assess the effect of food on the BA of a single oral dose of the AGMB-129 tablet formulation. A total of 24 participants will be enrolled. Participants will be randomized to 1 of 6 intervention sequences (Williams design) according to a 6-sequence, 3-period design. In 3 sequential intervention periods, each participant will receive 3 study interventions, 1 in each intervention period. The total duration of involvement for each participant, screening through follow-up, will be approximately 6 weeks.

NCT ID: NCT06388330 Completed - Clinical trials for Functional Dyspepsia

The Effect of a Low FODMAP Diet in Functional Dyspepsia Patients With Meal Related Symptoms

FFD
Start date: April 26, 2019
Phase: N/A
Study type: Interventional

In this study, the investigators will evaluate the FODMAP diet as an alternative treatment for functional dyspepsia and explore its effect on different aspects of the pathophysiology of FD.

NCT ID: NCT06369376 Completed - Clinical trials for New Nerve Conduction Protocol for Pectoral Nerve

Electrodiagnostic Approach for Pectoral Nerve Conduction Studies

Start date: June 30, 2023
Phase: N/A
Study type: Interventional

Anatomical studies have challenged traditional perceptions of the pectoral nerve structure, revealing a network of three branches rather than the previously accepted medial and lateral branches. This study aims to explore the implications of this updated anatomy on nerve conduction studies of the pectoral nerve and proposes a modified nerve conduction study protocol to enhance diagnostic accuracy. A study on 25 volunteers was conducted, examining the three parts of the pectoral nerve. Electrode placement followed a detailed methodology ensuring precise data collection. The nerve conduction study was performed bilaterally, exploring latency and amplitude while addressing inter-observer variability and demographic influences.

NCT ID: NCT06355869 Completed - Clinical trials for Spastic Cerebral Palsy

Repeatability of Gait Deviations in Children With Cerebral Palsy

Start date: August 17, 2021
Phase:
Study type: Observational

Three-dimensional gait analysis (3DGA) is the 'gold standard' for measurement and description of gait. Gait variability can arise from intrinsic and extrinsic factors and may vary between walking conditions. This study aimed to define the inter-trial (intrinsic) and inter-session (extrinsic) repeatability in gait analysis data of children with CP who were walking in four conditions, namely barefoot or with ankle-foot orthosis, and overground or treadmill.

NCT ID: NCT06355167 Completed - Clinical trials for Cardiovascular Diseases

Effect of Oral Intake of Bacopa Monneiri on Vascular Oxidative Stress

Bacoxy_I
Start date: March 15, 2022
Phase: N/A
Study type: Interventional

Bacoxy_I study aims to evaluate the efficacy of a standardized Bacopa monnieri extract, Bacopa-400®, on vascular oxidative stress.

NCT ID: NCT06340425 Completed - Cerebral Palsy Clinical Trials

The Effect of Selective Dorsal Rhizotomy on a Multidimensional Outcome Set in Children With Spastic Cerebral Palsy: a Retrospective Study

Start date: June 26, 2018
Phase:
Study type: Observational

Cerebral palsy or CP is the single largest cause of childhood physical disability, with a prevalence of 2-3 per 1000 livebirths. Children with CP experience different primary symptoms, including abnormal increased muscle tone or spasticity. Selective dorsal rhizotomy (SDR) is applied in children with spastic CP as a non-reversible tone reduction procedure. Better understanding of the effects of SDR on a multidimensional outcome set in one CP-cohort and on macroscopic muscle morphology can improve insights and clinical decision making.

NCT ID: NCT06321874 Completed - Abdominal Cancer Clinical Trials

Effects of Oxygen After Abdominal Oncological Surgery

EPHIRAS
Start date: January 1, 2011
Phase: N/A
Study type: Interventional

The aims of the research is to determine whether a Hyperoxic intermittent stimuli protocol can increase reticulocyte counts, signififying a rise in EPO production, in patients undergoing abdominal surgery